These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease. Anavekar SN; Barter C; Adam WR; Doyle AE J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S374-7. PubMed ID: 6184571 [TBL] [Abstract][Full Text] [Related]
5. Labetalol and pindolol in the treatment of hypertension: a comparative study. Romo M; Halttunen P; Saarinen P; Sarna S Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184 [TBL] [Abstract][Full Text] [Related]
6. Comparison of calcium antagonists with other antihypertensive agents. Doyle AE Am J Cardiol; 1986 Feb; 57(7):90D-92D. PubMed ID: 2869675 [TBL] [Abstract][Full Text] [Related]
7. Comparison of calcium antagonists with other antihypertensive agents. Doyle AE J Hypertens Suppl; 1985 Dec; 3(3):S531-3. PubMed ID: 2908821 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of verapamil in the treatment of hypertension. Anavekar SN; Doyle AE J Clin Hypertens; 1986 Sep; 2(3 Suppl):90S-99S. PubMed ID: 3540229 [TBL] [Abstract][Full Text] [Related]
9. Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study. Barnett AJ; Kalowski S; Guest C Med J Aust; 1978 Jan; 1(2):105-9. PubMed ID: 349319 [TBL] [Abstract][Full Text] [Related]
10. Comparison of labetalol with other anti-hypertensive drugs. Prichard BN; Richards DA Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):41S-47S. PubMed ID: 6124265 [TBL] [Abstract][Full Text] [Related]
11. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function. Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190 [TBL] [Abstract][Full Text] [Related]
12. Combined alpha- and beta-receptor inhibition in the treatment of hypertension. Prichard BN Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891 [TBL] [Abstract][Full Text] [Related]
13. Labetalol: a review of its pharmacology and therapeutic use in hypertension. Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1978 Apr; 15(4):251-70. PubMed ID: 25757 [TBL] [Abstract][Full Text] [Related]
14. Calcium antagonists and beta blockers in the control of mild to moderate systemic hypertension, with particular reference to verapamil and propranolol. Singh BN; Rebanal P; Piontek M; Nademanee K Am J Cardiol; 1986 Feb; 57(7):99D-105D. PubMed ID: 2869676 [TBL] [Abstract][Full Text] [Related]
15. Labetalol: an alpha- and beta-adrenoceptor blocking drug. Michelson EL; Frishman WH Ann Intern Med; 1983 Oct; 99(4):553-5. PubMed ID: 6137987 [TBL] [Abstract][Full Text] [Related]
16. The role of calcium channel blockers in the treatment of hypertension. Halperin AK; Cubeddu LX Am Heart J; 1986 Feb; 111(2):363-82. PubMed ID: 3511651 [No Abstract] [Full Text] [Related]